Multiple Myeloma With Advanced Bone Disease and Low Tumor Burden – Different Clinical Presentation but Similar Outcome After Bortezomib-Based Therapy and Radiotherapy

Acta Clinica Croatica - Croatia
doi 10.20471/acc.2017.56.02.09
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Sestre Milosrdnice University Hospital Center (KBC Sestre milosrdnice)

Related search

Different Presentation of Multiple Myeloma in Bone Marrow Aspiration

Journal of Cancer Science and Clinical Therapeutics
2018English

Clinical Outcomes of Bortezomib-Based Therapy in Taiwanese Patients With Multiple Myeloma: A Nationwide Population-Based Study and a Single-Institute Analysis

PLoS ONE
Multidisciplinary
2019English

Bortezomib-Based Consolidation or Maintenance Therapy for Multiple Myeloma: A Meta-Analysis

Blood Cancer Journal
OncologyHematology
2020English

A Dose Increased Once-Weekly Bortezomib-Based Combination Therapy for Multiple Myeloma

Oncotarget
Oncology
2016English

Response to Salvage Therapies and Outcome in Patients With Multiple Myeloma Relapsing After Pomalidomide Therapy

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Efficacy and Safety of Reduced-Intensity Induction Therapy With a Bortezomib-Based Regimen in Elderly Patients With Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2012English

Peripheral Neuropathy Induced by Subcutaneous Bortezomib-Based Induction Therapy for Newly Diagnosed Multiple Myeloma

Haematologica
Hematology
2014English

Bortezomib: The Evidence of Its Clinical Impact in Multiple Myeloma

Core Evidence
MedicineReviewsReferencesPharmacology
2006English

Repression of Multiple Myeloma Growth and Preservation of Bone With Combined Radiotherapy and Anti-Angiogenic Agent

Radiation Research
Nuclear MedicineRadiologyRadiationImagingBiophysics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy